Quantum量子訊息有限公司
← 最新全球產業報告

Animal Vaccines Market

研究執行與發布:Coherent Market Insights · 發布日期 2026-03-12 · 151 頁
由量子訊息有限公司(Quantum Information)在台灣代理銷售與提供授權諮詢。

2026 年市場規模
USD 9,815.7 Mn
2033 年預估規模
USD 15,275.6 Mn
年複合成長率 CAGR
6.6%

以上數字由 Coherent Market Insights 於本報告中提出,量子訊息原樣引用。

出版商 Coherent Market Insights產業別 Healthcare & Life Sciences出版日期 2026-03-12頁數 151報告編號 CMI4989

授權報價

Single User Price$4,500 USD
Enterprise License$10,000 USD
洽詢購買 申請 Sample
完整報告名稱與涵蓋範圍
Animal Vaccines Market, By Product Type (Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, Recombinant Vaccines), By Application (Companion Animal, Livestock Animal, Poultry, Aquaculture), By Distribution Channel (Veterinary Clinics, Veterinary Hospitals, Veterinary Research Institutes, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

報告摘要

Animal vaccines are parenteral products that are used as prophylactic as well as in the treatment of various veterinary diseases. Animal vaccines play a crucial role in ensuring good health, longevity, and improving overall productivity of pets and livestock, in a cost-effective manner. Companion animal vaccines reduce transmission of various diseases from animals to humans. These vaccines are parenteral products that are used in prophylactic treatment of various diseases such as blastomycosis, psittacosis cat scratch disease, and others. Market Dynamics Vaccines are preventive medicines for the treatment of various diseases. Some of the vaccines are expensive to afford. So various companies operating in the global animal vaccines market offer reimbursement to reduce the expenses of pet vaccinations which is expected to augment the market growth over the forecast period. For instance, For canine patients receiving an ULTRA Duramune DAP combination and Bronchi-Shield ORAL, Elanco reimburses normal and customary charges (up to US$ 5,000) associated with the diagnosis and treatment of any patient suffering respiratory disease due to canine parainfluenza virus infection Moreover, Elanco reimburses standard and reasonable diagnostics (a biopsy and histopathological exam) to reach a definitive diagnosis. With a confirmed diagnosis, Elanco reimburses standard and reasonable treatment costs up to US$ 1,500. For canine patients receiving an ULTRA Duramune DAP combination and Bronchi-Shield ORAL, Elanco reimburses normal and customary charges (up to US$ 5,000) associated with the diagnosis and treatment of any patient suffering respiratory disease due to canine parainfluenza virus infection. Moreover, various pet health insurance companies provide coverage for vaccines, examinations, teeth cleaning, spaying, and other pet health related activities. Some of the pet health insurance companies include ASPCA Pet Insurance, PetFirst Insurance, Embrace Pet Insurance Agency, and PetPlan, Allstate Insurance Company, among others. Key features of the study • This report provides an in-depth analysis of the global animal vaccines market, market size (US$ Mn), and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global animal vaccines market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, strategies. • Key companies covered as a part of this study include Merck & Co., Inc., Boehringer Ingelheim International GmbH., Zoetis Inc., Elanco Animal Health Incorporated, Ceva, HIPRA, Romvac Company Sa, Biovac, Vaxxinova International BV, and Biogénesis Bagó • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global animal vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global animal vaccines market Market Segmentation • By Product Type o Attenuated Live Vaccines o Conjugate Vaccines o Inactivated Vaccines o Subunit Vaccines o Toxoid Vaccines o DNA Vaccines o Recombinant Vaccines • By Application o Companion Animal o Livestock Animal o Poultry o Aquaculture • By Distribution Channel o Veterinary Clinics o Veterinary Hospitals o Veterinary Research Institutes o Others • By Region o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East & Africa  GCC Countries  Israel  Rest of Middle East & Africa • Key Players o Merck & Co., Inc. o Boehringer Ingelheim International GmbH. o Zoetis Inc. o Elanco Animal Health Incorporated o Ceva o HIPRA o Romvac Company Sa o Biovac o Vaxxinova International BV o Biogenesis Bago
目錄 Table of Contents
Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snapshot, By Product Type  Market Snapshot, By Application  Market Snapshot, By Distribution Channel  Market Snapshot, By Region o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Drivers and Restraints o Opportunities o Impact Analysis o Key developments o New Product Launches o Partnerships and Agreements o Technological Landscape o Brand Analysis o Regulatory Scenario o Epidemiology o Reimbursement Schemes o PORTER Analysis 4. Global Animal Vaccines Market, By Product Type, 2026 – 2033, (USD Mn) o Introduction  Market Share Analysis, 2021 and 2032 (%)  Y-o-Y Growth Analysis, 2026 – 2033  Segment Trends o Attenuated Live Vaccines  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn) o Conjugate Vaccines  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn) o Inactivated Vaccines  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn) o Subunit Vaccines  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn) o Toxoid Vaccines  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn) o DNA Vaccines  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn) o Recombinant Vaccines  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn) 5. Global Animal Vaccines Market, By Application, 2026 – 2033, (USD Mn) o Introduction  Market Share Analysis, 2021 and 2032 (%)  Y-o-Y Growth Analysis, 2026 – 2033  Segment Trends o Companion Animal  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn) o Livestock Animal  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn) o Poultry  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn) o Aquaculture  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn) 6. Global Animal Vaccines Market, By Distribution Channel, 2026 – 2033, (USD Mn) o Introduction  Market Share Analysis, 2021 and 2032 (%)  Y-o-Y Growth Analysis, 2026 – 2033  Segment Trends o Veterinary Clinics  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn) o Veterinary Hospitals  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn) o Veterinary Research Institutes  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2026 – 2033, (USD Mn) 7. Global Animal Vaccines Market, By Region, 2026 – 2033, (USD Mn) o Introduction  Market Share Analysis, By Region, 2021 and 2032 (%)  Y-o-Y Growth Analysis, For Regions, 2026–2032  Regional Trends o North America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 – 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 – 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 – 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country 2026 – 2033, (USD Mn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 – 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 – 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 – 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Mn) o Brazil o Mexico o Argentina o Rest of Latin America o Europe  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 – 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 – 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 – 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Mn) o U.K. o Germany o France o Italy o Spain o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 – 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 – 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 – 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Mn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 – 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 – 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 – 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Mn) o GCC o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 – 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 – 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 – 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 – 2033, (USD Mn) o North Africa o Central Africa o South Africa 8. Competitive Landscape o Company Profiles  Merck & Co., Inc. o Company Highlights o Product Portfolio o Key Highlights o Financial Performance o Strategies  Boehringer Ingelheim International GmbH o Company Highlights o Product Portfolio o Key Highlights o Financial Performance o Strategies  Zoetis Inc. o Company Highlights o Product Portfolio o Key Highlights o Financial Performance o Strategies  Elanco Animal Health Incorporated o Company Highlights o Product Portfolio o Key Highlights o Financial Performance o Strategies  Ceva o Company Highlights o Product Portfolio o Key Highlights o Financial Performance o Strategies  HIPRA o Company Highlights o Product Portfolio o Key Highlights o Financial Performance o Strategies  Romvac Company Sa o Company Highlights o Product Portfolio o Key Highlights o Strategies  Biovac o Company Highlights o Product Portfolio o Key Highlights o Strategies  Vaxxinova International BV o Company Highlights o Product Portfolio o Key Highlights o Strategies  Biogenesis Bago o Company Highlights o Product Portfolio o Key Highlights o Strategies 9. Section o Research Methodology o About Us

提及公司

Merck & Co., Inc.Boehringer Ingelheim International GmbH.Zoetis Inc.Elanco Animal Health IncorporatedCevaHIPRARomvac Company SaBiovacVaxxinova International BVBiogenesis Bago

同分類最新報告(醫療與生命科學)

常見問題

這份報告可以先索取樣本嗎?

可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算?

報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付?如何付款?

一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們